These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 12446435)

  • 1. Stem cell transplantation: supportive care and long-term complications.
    Wingard JR; Vogelsang GB; Deeg HJ
    Hematology Am Soc Hematol Educ Program; 2002; ():422-44. PubMed ID: 12446435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late complications in blood and marrow transplant survivors.
    Majhail NS
    Minn Med; 2010 Oct; 93(10):45-9. PubMed ID: 21140762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longterm followup and quality of life after hematopoietic stem cell transplantation.
    Sullivan KM
    J Rheumatol Suppl; 1997 May; 48():46-52. PubMed ID: 9150118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of secondary solid malignancies after allogeneic hematopoietic stem cell transplantation and preventive strategies.
    Adhikari J; Sharma P; Bhatt VR
    Future Oncol; 2015; 11(23):3175-85. PubMed ID: 26551415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up in hematopoietic stem-cell transplant patients.
    Fisher VL
    Pediatr Transplant; 1999; 3 Suppl 1():122-9. PubMed ID: 10587982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk for secondary thyroid carcinoma after hematopoietic stem-cell transplantation: an EBMT Late Effects Working Party Study.
    Cohen A; Rovelli A; Merlo DF; van Lint MT; Lanino E; Bresters D; Ceppi M; Bocchini V; Tichelli A; Socié G
    J Clin Oncol; 2007 Jun; 25(17):2449-54. PubMed ID: 17557958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome after allo-SCT: close follow-up on a large cohort treated with myeloablative regimens.
    Abou-Mourad YR; Lau BC; Barnett MJ; Forrest DL; Hogge DE; Nantel SH; Nevill TJ; Shepherd JD; Smith CA; Song KW; Sutherland HJ; Toze CL; Lavoie JC
    Bone Marrow Transplant; 2010 Feb; 45(2):295-302. PubMed ID: 19597425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reproductive issues in patients undergoing Hematopoietic Stem Cell Transplantation: an update.
    Guida M; Castaldi MA; Rosamilio R; Giudice V; Orio F; Selleri C
    J Ovarian Res; 2016 Nov; 9(1):72. PubMed ID: 27802832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What do we need to know about allogeneic hematopoietic stem cell transplant survivors?
    Clark CA; Savani M; Mohty M; Savani BN
    Bone Marrow Transplant; 2016 Aug; 51(8):1025-31. PubMed ID: 27064688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late effects of blood and marrow transplantation.
    Inamoto Y; Lee SJ
    Haematologica; 2017 Apr; 102(4):614-625. PubMed ID: 28232372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ferritin concentrations correlate to outcome of hematopoietic stem cell transplantation but do not serve as biomarker of graft-versus-host disease.
    Großekatthöfer M; Güclü ED; Lawitschka A; Matthes-Martin S; Mann G; Minkov M; Peters C; Seidel MG
    Ann Hematol; 2013 Aug; 92(8):1121-8. PubMed ID: 23604429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subsequent malignancies after allogeneic hematopoietic stem cell transplantation.
    Gündüz M; Özen M; Şahin U; Toprak SK; Civriz Bozdağ S; Kurt Yüksel M; Arslan Ö; Özcan M; Demirer T; Beksaç M; İlhan O; Gürman G; Topçuoğlu P
    Clin Transplant; 2017 Jul; 31(7):. PubMed ID: 28432802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late Complications and Quality of Life after Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation.
    Clavert A; Peric Z; Brissot E; Malard F; Guillaume T; Delaunay J; Dubruille V; Le Gouill S; Mahe B; Gastinne T; Blin N; Harousseau JL; Moreau P; Milpied N; Mohty M; Chevallier P
    Biol Blood Marrow Transplant; 2017 Jan; 23(1):140-146. PubMed ID: 27751934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic graft-versus-host disease and late effects after hematopoietic stem cell transplantation.
    Sanders JE
    Int J Hematol; 2002 Aug; 76 Suppl 2():15-28. PubMed ID: 12430895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral graft-versus-host disease.
    Kuten-Shorrer M; Woo SB; Treister NS
    Dent Clin North Am; 2014 Apr; 58(2):351-68. PubMed ID: 24655527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complications of allogeneic hematopoietic stem cell transplantation.
    Arnaout K; Patel N; Jain M; El-Amm J; Amro F; Tabbara IA
    Cancer Invest; 2014 Aug; 32(7):349-62. PubMed ID: 24902046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Graft-versus-host disease: a complex long-term side effect of hematopoietic stem cell transplant.
    Barton-Burke M; Dwinell DM; Kafkas L; Lavalley C; Sands H; Proctor C; Johnson E
    Oncology (Williston Park); 2008 Oct; 22(11 Suppl Nurse Ed):31-45. PubMed ID: 19856578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-Transplantation Natural Killer Cell Count: A Predictor of Acute Graft-Versus-Host Disease and Survival Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation.
    Kim SY; Lee H; Han MS; Shim H; Eom HS; Park B; Kong SY
    Clin Lymphoma Myeloma Leuk; 2016 Sep; 16(9):527-535.e2. PubMed ID: 27375156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral malignancies following HSCT: graft versus host disease and other risk factors.
    Demarosi F; Lodi G; Carrassi A; Soligo D; Sardella A
    Oral Oncol; 2005 Oct; 41(9):865-77. PubMed ID: 16084755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.